Docosahexaenoic acid 250 mg Oral Capsule
RxNorm 1100198 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Docosahexaenoic acid 250 mg Oral Capsule (RxCUI 1100198). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Exeltis USA, Inc 1
→ Exeltis USA, Inc. 1

Exeltis USA, Inc

NDC Product
Human Prescription Drug

Vitafol-ob Plus Dha Prenatal Supplement Plus Dha
NDC 0642-0076

Generic Name
Vitamin A, Ascorbic Acid, Vitamin D, .alpha.-tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, Copper, And Doconexent
Dosage Form
Kit
Route
N/A
Marketing
UNAPPROVED DRUG OTHER
Active Listing

Exeltis USA, Inc.

NDC Product
Human Prescription Drug

Select-ob Plus Dha Prenatal Supplement Plus Dha
NDC 0642-0075

Generic Name
.beta.-carotene, Vitamin A Acetate, Ascorbic Acid, Cholecalciferol, .alpha.-tocopherol Acetate, Dl-, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Levomefolate Calcium, Cobalamin, Iron, Magnesium Oxide, Zinc Oxide, And Doconexant
Dosage Form
Kit
Route
N/A
Marketing
UNAPPROVED DRUG OTHER
Active Listing